Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0800712105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Can Small Molecule Inhibitors of Glutaminyl Cyclase Be Used as a Therapeutic for Alzheimer's Disease?

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2017English

The Characterization of Microtubule-Stabilizing Drugs as Possible Therapeutic Agents for Alzheimer's Disease and Related Tauopathies

Pharmacological Research
Pharmacology
2011English

Technical Aspects of Amyloid Imaging for Alzheimer's Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2011English

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
2010English

Understanding Amyloid and Alzheimer's Disease

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2012English

Extracting -Amyloid From Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amyloid-Β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
2010English

Therapeutic Perspectives in Alzheimer's Disease

Recent Patents on CNS Drug Discovery
PsychiatryDrug DiscoveryMental HealthPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy